NEW YORK (GenomeWeb) – Canadian molecular diagnostics company GeneNews announced today that it has received notice that the Toronto Stock Exchange is reviewing its eligibility to remain listed on the TSX. GeneNews has 60 days to show that it is in compliance with the continued listing requirements of the exchange.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The New York Times Magazine writes that proteomics might be better poised than genomics to say when someone is falling ill.

Bloomberg profiles IndieBio, a startup incubator for the life sciences.

In an editorial, Nature calls for the end to the exploitation of foreign postdocs.

In Nucleic Acids Research this week: collection of epigenome-wide association study data, updated BloodSpot database, and more.